NYSE:AVTR • US05352A1007
The current stock price of AVTR is 9.06 USD. In the past month the price decreased by -22.23%. In the past year, price decreased by -45.75%.
ChartMill assigns a fundamental rating of 4 / 10 to AVTR. While AVTR is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months AVTR reported a non-GAAP Earnings per Share(EPS) of 0.91. The EPS decreased by -9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.5% | ||
| ROE | -9.53% | ||
| Debt/Equity | 0.7 |
26 analysts have analysed AVTR and the average price target is 12.92 USD. This implies a price increase of 42.56% is expected in the next year compared to the current price of 9.06.
For the next year, analysts expect an EPS growth of 0.81% and a revenue growth -0.48% for AVTR
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.69 | 192.995B | ||
| DHR | DANAHER CORP | 24.67 | 148.11B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 143.62 | 47.72B | ||
| A | AGILENT TECHNOLOGIES INC | 18.7 | 35.276B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.85 | 28.054B | ||
| IQV | IQVIA HOLDINGS INC | 12.38 | 27.46B | ||
| WAT | WATERS CORP | 22.08 | 19.016B | ||
| ILMN | ILLUMINA INC | 23.54 | 18.622B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.58 | 17.832B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.06 | 12.341B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
AVANTOR INC
Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road
Radnor PENNSYLVANIA 19087 US
CEO: Michael Stubblefield
Employees: 13500
Phone: 16103861700
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
The current stock price of AVTR is 9.06 USD. The price decreased by -0.55% in the last trading session.
AVTR does not pay a dividend.
AVTR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
26 analysts have analysed AVTR and the average price target is 12.92 USD. This implies a price increase of 42.56% is expected in the next year compared to the current price of 9.06.
AVANTOR INC (AVTR) has a market capitalization of 6.18B USD. This makes AVTR a Mid Cap stock.
The outstanding short interest for AVANTOR INC (AVTR) is 5.73% of its float.